Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis.

Arvind, Ashwini; Memel, Zoe N; Philpotts, Lisa L; Zheng, Hui; Corey, Kathleen E; Simon, Tracey G

Arvind, Ashwini; Memel, Zoe N; Philpotts, Lisa L; Zheng, Hui; Corey, Kathleen E; Simon, Tracey G.

Afiliação

Arvind A; Harvard Medical School, Boston, MA, United States of America; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, United States of America.
Memel ZN; Harvard Medical School, Boston, MA, United States of America; Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.
Philpotts LL; Treadwell Library, Massachusetts General Hospital, Boston, MA, United States of America.
Zheng H; Harvard Medical School, Boston, MA, United States of America; Biostatistics Center, Massachusetts General Hospital, Boston, MA, United States of America.
Corey KE; Harvard Medical School, Boston, MA, United States of America; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, United States of America; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, United States of America.
Simon TG; Harvard Medical School, Boston, MA, United States of America; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, United States of America; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, United States of America. Electron

Metabolism ; 120: 154780, 2021 07.

Article em En | MEDLINE | ID: mdl-33891949

Assuntos

Carcinoma Hepatocelular/epidemiologia; Hipoglicemiantes/uso terapêutico; Neoplasias Hepáticas/epidemiologia; Idoso; Benzamidas/uso terapêutico; Carcinoma Hepatocelular/etiologia; Diabetes Mellitus Tipo 2/tratamento farmacológico; Diabetes Mellitus Tipo 2/epidemiologia; Inibidores de Glicosídeo Hidrolases/uso terapêutico; Humanos; Hipoglicemiantes/classificação; Incidência; Neoplasias Hepáticas/etiologia; Pessoa de Meia-Idade; Fatores de Risco; Compostos de Sulfonilureia/uso terapêutico; Tiazolidinedionas/uso terapêutico

Palavras-chave

Alpha-glucosidase inhibitors; Carcinoma, hepatocellular; Diabetes mellitus, type 2; Thiazolidinediones

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hipoglicemiantes / Neoplasias Hepáticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google